Navigation Links
Sonendo Agrees To Terms For Up To $20 Million In Financing
Date:6/28/2012

LAGUNA HILLS, Calif., June 28, 2012 /PRNewswire/ -- Sonendo, Inc. (formerly known as Dentatek Corporation), a privately-held company developing disruptive technologies to transform endodontic therapy, announced today that it has agreed to terms for a $20 million equity financing of which $9.2 million has been invested in an initial closing.  The round was led by OrbiMed Advisors, LLC, with NeoMed Management joining existing investors, including Fjord Ventures Management.  The proceeds from the financing will be used to finalize technology development, fund clinical studies and commercialize Sonendo's first endotherapy system.  Vince Burgess of OrbiMed and Erik Amble of NeoMed have joined the company's board of directors.      

Vince Burgess, Venture Partner at OrbiMed Advisors, noted, "We look to invest in companies, like Sonendo, that have disruptive technologies in large markets.  In the United States alone there are more than 15 million root canal procedures performed every year, nearly all of which utilize simple metal files and too often yield imperfect results.  We believe Sonendo's proprietary technology, once fully developed, has the potential to change the standard of care for root canal procedures."

Bjarne Bergheim, Chief Executive Officer of Sonendo, said, "We are encouraged that this group of premier investors has recognized the potential of Sonendo to transform root canal therapy.  This investment will help us achieve our goal of improving traditional endodontic procedures with a focus on clinical outcomes and patient comfort."

About Sonendo, Inc. - Founded in 2006 as Dentatek Corporation by life science-focused accelerator Fjord Ventures, LLC, Sonendo is a privately-held pre-revenue stage company developing innovative technologies to transform endodontic therapy.

About OrbiMed Advisors, LLC - OrbiMed Advisors is the largest healthcare-dedicated fund manager in the world. With approximately $5 billion under management and offices in New York, San Francisco, Tel Aviv, Shanghai, and Mumbai, OrbiMed offers the global resources to be an exceptional long term partner for its portfolio companies. For more information, please visit: www.OrbiMed.com

About NeoMed Management - NeoMed Management is an international investment firm, exclusively focusing on the healthcare industry. Founded in 1996, NeoMed has established five funds, with total committed capital exceeding $250 million. NeoMed invests in emerging medical products companies with outstanding growth prospects. For more information please visit: www.neomed.net

About Fjord Ventures, LLC - Fjord Ventures is a life-science focused technology accelerator that provides operational management expertise and a highly capital efficient shared infrastructure to portfolio companies.  Financing alternatives are available through Fjord Ventures Management.  For more information, please visit: www.fjordventures.com

Forward-Looking Statements
This announcement contains forward-looking statements that are based on management's beliefs, assumptions and expectations and on information currently available to management.  All statements that address events or developments that we expect or anticipate will occur in the future are forward-looking statements, including without limitation our expectations with respect to the timing and progress of research and development activities. Management believes that these forward-looking statements are reasonable as and when made.  However, you should not place undue reliance on forward-looking statements because they speak only as of the date when made.  Sonendo does not assume any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.  Actual results, developments or events could differ materially from those disclosed in the forward-looking statements. 

Company Contacts:
Matt Clawson
Allen & Caron Inc
(949) 474-4300
matt@allencaron.com

Media:
Len Hall
Allen & Caron Inc
(949) 474-4300
len@allencaron.com


'/>"/>
SOURCE Sonendo, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
2. Kensey Nash Agrees to Be Acquired by DSM for $38.50 per Share in Cash
3. Vaccine Partnering Terms and Agreements
4. Benvenue Medical Secures $25 Million Series D Financing
5. Practice Fusion Announces $34 Million in Financing Led by Artis Ventures
6. Abbott, The Abbott Fund And Direct Relief International Reach Key HIV Testing Milestones: 20 Million Tests Provided Over 10 Years, And More Than 150,000 HIV Cases Prevented In Children
7. Omeros Prices $30 Million Public Offering of Common Stock
8. Spot On Sciences Awarded $1 Million DARPA Grant to Develop a Blood Sample Collection Device
9. Developers: Deadline Approaching for Allscripts Million Hearts CDS Challenge
10. Biodel Announces $18.5 Million Private Placement
11. The Michael J. Fox Foundation Launches The $14 Million-Edmond J. Safra Core Programs for PD Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2017)... , May 30, 2017 Therapix Biosciences Ltd. ... specializing in the development of cannabinoid-based drugs, today ... company overview at three upcoming scientific and investor ... LD Micro Invitational: ... Date:                     ...
(Date:5/24/2017)... , May 24, 2017  ivWatch LLC ... Equipment Manufacturer (OEM) Board to enable seamless integration ... patient monitoring systems, infusion pumps and other devices. ... will be able to help health care customers ... reduced risks related to IV therapy. ...
(Date:5/18/2017)... -- Two Bayer U.S. Pharmaceutical leaders received top awards from ... th Woman of the Year event ... mission of furthering the advancement and impact of women ... Powell-Steffen , senior director of brand activation and inside ... Howe , a regional business manager for New England ...
Breaking Medicine Technology:
(Date:6/25/2017)... ... June 25, 2017 , ... CareSet Labs released the Root NPI ... This is a new, greatly improved version of the Doctor Referral teaming dataset commonly ... Fred Trotter and subsequently called the the “Doctor Referral Dataset” as released by Medicare ...
(Date:6/24/2017)... ... June 24, 2017 , ... Genes Advice, a new company ... Florida and Texas doctors' offices and clinics. This breakthrough testing is part of ... recognizes the role genes play in determining an individual's tolerance of and reaction ...
(Date:6/24/2017)... ... , ... The weather is heating up and the days are getting longer, ... aware that the summer months provide more than warmer temperatures that are perfect for ... negatively affected from direct exposure to the sun. When it comes to the security ...
(Date:6/23/2017)... ... June 23, 2017 , ... "The Better Care Reconciliation Act ... harm to people with all chronic conditions, including mental illnesses, while increasing the ... the Affordable Care Act (ACA) requirement that insurers cover pre-existing conditions, it does ...
(Date:6/23/2017)... ... 24, 2017 , ... Studies show evidence that carotenoids and antioxidants derived either ... in these patients. , But how often do ophthalmologists and optometrists in Sweden recommend ... risk of or with early symptoms of AMD? A study published recently ...
Breaking Medicine News(10 mins):